AI
PMC

Analytic Investors’s PharMerica Corporation PMC Stock Holding History

Analytic Investors’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$395K Sell
14,067
-1,939
-12% -$49.7K ﹤0.01% 506
2016
Q2 		$395K Hold
16,006
– – ﹤0.01% 494
2016
Q1 		$353K Buy
+16,006
New +$426K ﹤0.01% 520

Other funds holding PMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Analytic Investors's PMC Position: Q3 2016 in Review

Analytic Investors reduced its PharMerica Corporation (PMC) stake by 12% in Q3 2016, selling an estimated $49.7K and leaving 14,067 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Analytic Investors first reported a position in PMC in Q1 2016 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold PMC as of Q3 2016.

  • Analytic Investors held 14,067 shares of PharMerica Corporation worth $395K as of Q3 2016.
  • Analytic Investors sold 1,939 PharMerica Corporation shares in Q3 2016, an estimated $49.7K.
  • PharMerica Corporation made up ﹤0.01% of Analytic Investors's portfolio in Q3 2016, its #506 holding.
  • Analytic Investors first reported a position in PharMerica Corporation in Q1 2016 and has held it in 3 quarters since.
  • 172 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.